Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alexander Zipprich

Showing results (51-60 of 111) with videos related to

Pageof 12
Sort By:
Zeitschrift Fur Gastroenterologie|February 7, 2025
Liver transplantation in alcohol-induced acute-on-chronic liver failure without six months of abstinenceFalk Rauchfuss, Laura Schwenk, Philipp A Reuken, et al.
Journal of Gastrointestinal and Liver Diseases : JGLD|March 28, 2025
Machine Learning Models predicting Decompensation in CirrhosisSophie Elisabeth Müller, Markus Casper, Cristina Ripoll, et al.
JHEP Reports : Innovation in Hepatology|March 20, 2026
Performance of reMELD-Na as a predictor of short-term mortality in patients with cirrhosis and ascitesStefanie Quickert, Karsten Große, Elisa Selina Grubert, et al.
Gut|June 29, 2010
Incorporating indocyanin green clearance into the Model for End Stage Liver Disease (MELD-ICG) improves prognostic accuracy in intermediate to advanced cirrhosisAlexander Zipprich, Oliver Kuss, Sebastian Rogowski, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|February 28, 2021
Isolated bacterial infection without decompensation has no impact on survival of compensated patients with cirrhosisMatthias C Reichert, Christina Schneider, Robin Greinert, et al.
Clinical and Translational Gastroenterology|February 1, 2019
Common NOD2 Risk Variants as Major Susceptibility Factors for Bacterial Infections in Compensated CirrhosisMatthias Christian Reichert, Cristina Ripoll, Markus Casper, et al.
Trials|April 5, 2023
Liver-HERO: hepatorenal syndrome-acute kidney injury (HRS-AKI) treatment with transjugular intrahepatic portosystemic shunt in patients with cirrhosis-a randomized controlled trialCristina Ripoll, Stephanie Platzer, Philipp Franken, et al.
BMC Cardiovascular Disorders|October 21, 2024
Association of liver dysfunction with outcomes after percutaneous coronary intervention - a systematic review and meta-analysisTulio Caldonazo, Hristo Kirov, Panagiotis Tasoudis, et al.
European Journal of Gastroenterology & Hepatology|December 19, 2019
Transjugular intrahepatic portosystemic shunt for patients with liver cirrhosis: survey evaluating indications, standardization of procedures and anticoagulation in 43 German hospitalsChristian J Steib, Hanwei Li, Jiang Zhang, et al.
Journal of Hepatology|March 21, 2025
Effect of albumin treatment duration on response rates and outcomes in patients with cirrhosis and acute kidney injuryEva Maria Schleicher, Henrik Karbannek, Julia Weinmann-Menke, et al.
Pageof 12

Showing results (51-60 of 111) with videos related to

Sort By:
Pageof 12
Zeitschrift Fur Gastroenterologie|February 7, 2025
Liver transplantation in alcohol-induced acute-on-chronic liver failure without six months of abstinenceFalk Rauchfuss, Laura Schwenk, Philipp A Reuken, et al.
Journal of Gastrointestinal and Liver Diseases : JGLD|March 28, 2025
Machine Learning Models predicting Decompensation in CirrhosisSophie Elisabeth Müller, Markus Casper, Cristina Ripoll, et al.
JHEP Reports : Innovation in Hepatology|March 20, 2026
Performance of reMELD-Na as a predictor of short-term mortality in patients with cirrhosis and ascitesStefanie Quickert, Karsten Große, Elisa Selina Grubert, et al.
Gut|June 29, 2010
Incorporating indocyanin green clearance into the Model for End Stage Liver Disease (MELD-ICG) improves prognostic accuracy in intermediate to advanced cirrhosisAlexander Zipprich, Oliver Kuss, Sebastian Rogowski, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|February 28, 2021
Isolated bacterial infection without decompensation has no impact on survival of compensated patients with cirrhosisMatthias C Reichert, Christina Schneider, Robin Greinert, et al.
Clinical and Translational Gastroenterology|February 1, 2019
Common NOD2 Risk Variants as Major Susceptibility Factors for Bacterial Infections in Compensated CirrhosisMatthias Christian Reichert, Cristina Ripoll, Markus Casper, et al.
Trials|April 5, 2023
Liver-HERO: hepatorenal syndrome-acute kidney injury (HRS-AKI) treatment with transjugular intrahepatic portosystemic shunt in patients with cirrhosis-a randomized controlled trialCristina Ripoll, Stephanie Platzer, Philipp Franken, et al.
BMC Cardiovascular Disorders|October 21, 2024
Association of liver dysfunction with outcomes after percutaneous coronary intervention - a systematic review and meta-analysisTulio Caldonazo, Hristo Kirov, Panagiotis Tasoudis, et al.
European Journal of Gastroenterology & Hepatology|December 19, 2019
Transjugular intrahepatic portosystemic shunt for patients with liver cirrhosis: survey evaluating indications, standardization of procedures and anticoagulation in 43 German hospitalsChristian J Steib, Hanwei Li, Jiang Zhang, et al.
Journal of Hepatology|March 21, 2025
Effect of albumin treatment duration on response rates and outcomes in patients with cirrhosis and acute kidney injuryEva Maria Schleicher, Henrik Karbannek, Julia Weinmann-Menke, et al.
Pageof 12